Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 20-Oct-2020
No. of pages: 97
Inquire Before Buying

Global Monoclonal Antibody Therapeutics Scope and Market Size

Monoclonal Antibody Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into

- Humanized Antibody

- Human Mouse Chimeric Antibody

Market segment by Application, split into

- Cancer

- Autoimmune Diseases

- Infection

- Hematological Diseases

- Ophthalmological Diseases

- Others

Based on regional and country-level analysis, the Monoclonal Antibody Therapeutics market has been segmented as follows:

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Monoclonal Antibody Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

The key players covered in this study

- Bayer

- F. Hoffmann-La Roche

- Pfizer

- Sanofi

- GlaxoSmithKline

- Merck

- Novartis

- AbbVie

- Amgen

- Johnson & Johnson

- Bristol-Myers Squibb Company

- Biogen

Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Therapeutics Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Market Size
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2019
3.5 Key Players Monoclonal Antibody Therapeutics Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2021-2026)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2015-2026)
6.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2015-2026)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Monoclonal Antibody Therapeutics Market Size (2015-2026)
8.2 China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
8.3 China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
8.4 China Monoclonal Antibody Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Monoclonal Antibody Therapeutics Market Size (2015-2026)
9.2 Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
9.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
9.4 Japan Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
10.11.1 Bristol-Myers Squibb Company Company Details
10.11.2 Bristol-Myers Squibb Company Business Overview
10.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
10.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
10.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
10.12.1 Biogen Company Details
10.12.2 Biogen Business Overview
10.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
10.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
10.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Human Mouse Chimeric Antibody
Table 5. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Monoclonal Antibody Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Monoclonal Antibody Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026)
Table 11. Monoclonal Antibody Therapeutics Market Market Trends
Table 12. Monoclonal Antibody Therapeutics Market Drivers
Table 13. Monoclonal Antibody Therapeutics Market Challenges
Table 14. Monoclonal Antibody Therapeutics Market Restraints
Table 15. Global Monoclonal Antibody Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Monoclonal Antibody Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019)
Table 18. Global Monoclonal Antibody Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Monoclonal Antibody Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 30. North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 40. China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 42. China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 44. China Monoclonal Antibody Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Monoclonal Antibody Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 58. Bayer Company Details
Table 59. Bayer Business Overview
Table 60. Bayer Product
Table 61. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 62. Bayer Recent Development
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Product
Table 66. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Product
Table 71. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Product
Table 76. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 77. Sanofi Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 87. Merck Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 92. Novartis Recent Development
Table 93. AbbVie Business Overview
Table 94. AbbVie Product
Table 95. AbbVie Company Details
Table 96. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Product
Table 101. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 102. Amgen Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Business Overview
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 107. Johnson & Johnson Recent Development
Table 108. Bristol-Myers Squibb Company Company Details
Table 109. Bristol-Myers Squibb Company Business Overview
Table 110. Bristol-Myers Squibb Company Product
Table 111. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 112. Bristol-Myers Squibb Company Recent Development
Table 113. Biogen Company Details
Table 114. Biogen Business Overview
Table 115. Biogen Product
Table 116. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 117. Biogen Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Humanized Antibody Features
Figure 3. Human Mouse Chimeric Antibody Features
Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Autoimmune Diseases Case Studies
Figure 7. Infection Case Studies
Figure 8. Hematological Diseases Case Studies
Figure 9. Ophthalmological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026)
Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Players in 2019
Figure 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2019
Figure 18. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 47. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 48. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 50. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 51. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 52. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 53. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 54. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 56. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs